Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of lymphomas.

B Schnitzer1

  • 1University of Michigan Medical Center, Ann Arbor.

CRC Critical Reviews in Clinical Laboratory Sciences
|January 1, 1978
PubMed
Summary
This summary is machine-generated.

Malignant lymphomas, including Hodgkin's disease and non-Hodgkin's lymphomas, have evolving classification systems. This review covers current and modern schemes for these immune system neoplasms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.

Leukemia·2005
Same author

Primary diagnosis of whipple disease manifesting as lymphadenopathy: use of polymerase chain reaction for detection of Tropheryma whippelii.

American journal of clinical pathology·2002
Same author

Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.

American journal of clinical pathology·2001
Same author

Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001
Same author

The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma.

American journal of clinical pathology·2001
Same author

Follicular lymphoma with marginal zone differentiation: microdissection demonstrates the t(14;18) in both the follicular and marginal zone components.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001
Same journal

Problems associated with clinical chemistry quality control materials.

CRC critical reviews in clinical laboratory sciences·1980
Same journal

Binding of bilirubin to albumin.

CRC critical reviews in clinical laboratory sciences·1980
Same journal

Soluble immune complexes in human disease.

CRC critical reviews in clinical laboratory sciences·1980
Same journal

Transfer factor.

CRC critical reviews in clinical laboratory sciences·1980
Same journal

Structural, functional, and clinical aspects of gamma-glutamyltransferase.

CRC critical reviews in clinical laboratory sciences·1980
Same journal

Screening tests for cell-mediated immunodeficiency diseases.

CRC critical reviews in clinical laboratory sciences·1979
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Malignant lymphomas are cancers of immune system cells, with classification historically being complex.
  • Progress has been made in developing prognostically significant lymphoma classifications.
  • Lymphomas are broadly categorized into Hodgkin's disease and non-Hodgkin's lymphomas.

Purpose of the Study:

  • To review current and modern classification systems for lymphomas.
  • To describe subclassifications and differential diagnoses of lymphomas.
  • To highlight the evolution of lymphoma classification.

Main Methods:

  • Review of existing literature on lymphoma classification.
  • Comparison of traditional morphologic criteria with modern immunologic techniques.

Related Experiment Videos

  • Discussion of accepted schemes like the Rye classification for Hodgkin's disease.

    • Main Results:

    • The Rye classification for Hodgkin's disease is globally accepted.
    • Significant debate persists regarding non-Hodgkin's lymphoma classification schemes.
    • Modern classifications integrate morphology with immunologic data.

    Conclusions:

    • Lymphoma classification is advancing, moving beyond purely morphologic assessments.
    • Understanding subclassifications is crucial for accurate diagnosis and treatment.
    • Distinguishing lymphomas from mimics requires careful clinicopathologic and immunologic evaluation.